Affiliations 

  • 1 Department of Pharmaceutical Sciences, Babasaheb Bhimrao Ambedkar University, Lucknow, India
  • 2 School of Pharmacy, Taylor's University Lakeside Campus, Kuala Lumpur, Malaysia
  • 3 Department of Microbiology, Babasaheb Bhimrao Ambedkar University, Lucknow, India
  • 4 Ashland Specialties Chemicals India Ltd, Innovation and Pharma R&D, MN Park Synergy Square 3, Building Number 2700, Shamirpet, Hyderabad 500078 Telangana, India
  • 5 Ashland Specialties Chemicals Ireland Ltd, Innovation and Pharma R&D, National Science Park, Building V, Dublin Road, Petitswood, Mullingar, Ireland
Biomed Mater, 2023 Mar 27;18(3).
PMID: 36921352 DOI: 10.1088/1748-605X/acc4a1

Abstract

The morbidity rate following a surgical procedure increasing rapidly in the cases associated with surgical site infections. Traditional sutures lack the ability to deliver drugs as the incorporation of the drug in their structure would hamper their mechanical properties. To prevent such infections, we developed an extracellular matrix mimicking electrospun nanofibrous yarns of poly-(D,L)-lactic acid and polyvinyl alcohol loaded with vancomycin and ferulic acid, prepared by uniaxial electrospinning technique.In-vitrocharacterization such as scanning electron microscopy, Fourier transform infrared spectroscopy, x-ray diffraction, tensile strength testing, degradation studies, and antimicrobial studies along within-vivoevaluation done with help of incision wound healing rat model and simultaneous testing of microbial load in the incised tissue. Thein-vitrostudies indicated the nanofiber yarns have size range 200-300 nm with a tensile strength of 7.54 ± 0.58 MPa. The dual drug-loaded yarn showed sustained drug release over a period of 48 h.In-vitrowater uptake and biodegradation data indicated optimum results suitable for suturing applications. Antimicrobial study showed excellent antimicrobial activity against bothS. aureus and E. coli.Results obtained fromin-vivostudy suggested excellent wound healing potential of nanofiber yarns as compared with commercial silk sutures. The histopathological studies confirmed restoring ability of nanofiber yarn to the normal skin structure. Enzyme-linked immunosorbent assay (ELISA) study revealed the downregulation of inflammatory markers i.e. TNF-alpha and IL-6, making nanofibers sutures suitable for surgical wound healing applications. Overall, the present study may conclude that the developed dual drug-loaded nanofiber yarns have excellent potential in surgical wound healing applications.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.